Efficacy of MVA-NP+M1 in the Influenza H3N2 Human Challenge Model

NCT03883113 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: MVA-NP+M1
BIOLOGICAL: Saline
BIOLOGICAL: H3N2 (A/Belgium/2417/2015)

Sponsor

Barinthus Biotherapeutics